Several legal considerations are key to protect the buyer and seller in royalty interest transactions.
Jeffrey A. Jung
Advertisement
Jeffrey A. Jung is a partner at McDermott, Will & Emery LLP
Articles by Jeffrey A. Jung
Advertisement
Latest Updated Articles
Royalty Interest Investing: Addressing the Out-License Assignability IssuePublished: May 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
